Search results for "lasi"

showing 10 items of 1298 documents

Clinical and radiographic features of pycnodysostosis: A case report

2017

Pycnodysostosis is a rare disorder that was first described in 1962; however, it was only in 1996 that the defective gene was discovered, which led to a better understanding of this disease. This study reports and discuss a case of pycnodysostosis. In addition, a search of articles published in PubMed-Medline was performed. The case was a 13-year-old girl who was referred to a private clinic for dental treatment. Clinical examination showed midface hypoplasia, prominent cheeks, a high nasal bridge, beaked nose, spoon-shaped fingers, frontal bossing, open fontanelles and dental alterations, findings compatible with pycnodysostosis. Patients with this disease also suffer from fractures becaus…

medicine.medical_specialtyOral Medicine and Pathologymedicine.diagnostic_testNasal bridgebusiness.industryRadiographyCase ReportPhysical examination030206 dentistryDiseaseProminent cheeks:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyMidface hypoplasia03 medical and health sciencesFrontal Bossing0302 clinical medicineUNESCO::CIENCIAS MÉDICASPycnodysostosismedicinebusinessGeneral Dentistry030217 neurology & neurosurgeryJournal of Clinical and Experimental Dentistry
researchProduct

Chromoendoscopy in Barrett's oesophagus: is cresyl violet the magic bullet?

2006

The endoscopic detection of Barrett’s epithelium remains challenging even for modern endoscopy. This is mainly due to the fact that Barrett’s epithelium is often patchy and can easily be overlooked by conventional endoscopy with random biopsies. Thus, chromoendoscopy and magnifying endoscopy were introduced to facilitate diagnosis of Barrett’s epithelium and Barrett’s associated neoplasias. Methylene blue-aided chromoendoscopy was firstly introduced by Canto et al. [1]. The authors could show that methylene blue selectively stains specialised columnar epithelium, which is pathognomonic for Barrett’s epithelium. In contrast, dysplastic areas revealed no or weaker staining due to changes in t…

medicine.medical_specialtyPathologyGastroenterologyChromoendoscopyBarrett EsophagusInternal medicineOxazinesmedicineHumansEndoscopy Digestive SystemVillous PatternColoring AgentsHepatologymedicine.diagnostic_testbusiness.industryGastroenterologymedicine.diseaseEpitheliumEndoscopyStainingBenzoxazinesAutofluorescencemedicine.anatomical_structureDysplasiaMagic bulletbusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes

2012

The reproducibility of the World Health Organization 2008 classification for myelodysplastic syndromes is uncertain and its assessment was the major aim of this study. The different peripheral blood and bone marrow variables required for an adequate morphological classification were blindly evaluated by four cytomorphologists in samples from 50 patients with myelodysplastic syndromes. The degree of agreement among observers was calculated using intraclass correlation coefficient and the generalized kappa statistic for multiple raters. The degree of agreement for the percentages of blasts in bone marrow and peripheral blood, ring sideroblasts in bone marrow, and erythroid, granulocytic and m…

medicine.medical_specialtyPathologyHematologymedicine.diagnostic_testbusiness.industryMyelodysplastic syndromesHematologyErythroid dysplasiamedicine.diseaseGastroenterologyBone marrow examinationmedicine.anatomical_structureInternal medicineRefractory anemia with ring sideroblastsmedicineBone marrowRefractory anemia with excess of blastsbusinessErythroid Precursor Cells
researchProduct

CD1A IMMUNOPOSITIVITY COULD HELP TO DISTINGUISH BARRETT's METAPLASIA FROM HETEROTOPIC GASTRIC MUCOSA

2005

medicine.medical_specialtyPathologyHepatologybusiness.industryGastroenterologyGastroenterologyCD1a Barrettmedicine.anatomical_structureInternal medicineMetaplasiaGastric mucosaMedicinemedicine.symptombusinessJournal of Gastroenterology and Hepatology
researchProduct

The Man Behind the Eponym: Hans Biberstein and Follicular Hyperplasia Overlying Dermatofibroma

2009

Hans Biberstein first described the basaloid follicular hyperplasia overlying dermatofibromas in 1923 and published his extensive observations on the subject in 1931. Part of Josef Jadassohn's department in Breslau, he was forced to leave German by the National Socialist regime and spent the rest of his career in New York. After a hiatus of 30 years, the dermatopathologic literature once again began addressing his seminal finding but never gave him proper credit. We suggest Biberstein's sign as an appropriate term for basaloid follicular hyperplasia overlying a dermatofibroma and as a small tribute to a pioneer dermatopathologist.

medicine.medical_specialtyPathologyHyperplasiaSkin Neoplasmsmusic.instrumentHistiocytoma Benign Fibrousbusiness.industryEponymDermatologyGeneral MedicineHistory 20th Centurymedicine.diseaseDermatofibromaDermatologyFollicular hyperplasiaPathology and Forensic MedicinePathologymedicineFibromabusinessmusicThe American Journal of Dermatopathology
researchProduct

Expression of Cytokeratin 7 and 20 in Pathological Conditions of the Bile Tract

2003

Expression of cytokeratin 7 (CK7) and cytokeratin 20 (CK20) helps to establish the origin of biliary and metastatic carcinomas. We investigated the expression of CK7 and CK20 in inflammatory, metaplastic and neoplastic conditions of the bile ducts, and evaluated possible relationships between the CK expression pattern and extrahepatic bile duct/gallbladder carcinomas (EBDCs) or intrahepatic bile duct carcinomas (IBDCs). We used immunohistochemistry for the investigation of 48 formalin-fixed, paraffin-embedded specimens grouped as: A) lithiasic or inflamed surgically resected extrahepatic bile ducts/gallbladders: all were CK7+/CK20+; B) percutaneous liver biopsies from patients with chronic …

medicine.medical_specialtyPathologyIntestinal metaplasia2734Intrahepatic bile ductsBile duct tumors; Cytokeratin 20 (CK20); Cytokeratin 7 (CK7); Intestinal metaplasia; Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts Extrahepatic; Bile Ducts Intrahepatic; Carcinoma; Cell Transformation Neoplastic; Gallbladder Diseases; Gallbladder Neoplasms; Gene Expression Profiling; Humans; Immunohistochemistry; Intermediate Filament Proteins; Keratin-20; Keratin-7; Keratins; 2734Bile Duct DiseasesGallbladder DiseasesKeratin-20Settore MED/08 - Anatomia PatologicaGastroenterologyIntermediate Filament ProteinPathology and Forensic MedicinePrimary sclerosing cholangitisCytokeratinPrimary biliary cirrhosisIntermediate Filament ProteinsBile Ducts ExtrahepaticInternal medicineBile duct tumormedicineHumansCytokeratin 7 (CK7)Bile Duct NeoplasmGallbladder NeoplasmBile ductbusiness.industryGene Expression ProfilingGallbladderKeratin 20CarcinomaGallbladder DiseaseKeratin-7Bile Duct DiseaseCell Biologymedicine.diseaseImmunohistochemistryBile Ducts IntrahepaticCell Transformation Neoplasticmedicine.anatomical_structureBile Duct NeoplasmsKeratinKeratin 7KeratinsGallbladder NeoplasmsbusinessCytokeratin 20 (CK20)HumanPathology - Research and Practice
researchProduct

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future dir…

2010

Abstract After publication of the updated World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues in 2008, the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph) now presents an update of the hierarchical classification of lymphoid neoplasms for epidemiologic research based on the 2001 WHO classification, which we published in 2007. The updated hierarchical classification incorporates all of the major and provisional entities in the 2008 WHO classification, including newly defined entities based on age, site, certain infections, and molecular characteristics, as well as borderline categories, early and “in situ” …

medicine.medical_specialtyPathologyLymphoid NeoplasiaLymphomabusiness.industryImmunologyMEDLINELymphoproliferative disordersCell BiologyHematologyComputational biologyWorld Health Organizationmedicine.diseaseBiochemistryWorld healthLymphomaEpidemiologic StudiesEpidemiologymedicineHumansLymphoid neoplasmsEpidemiologic researchbusinessWho classificationSocieties MedicalBlood
researchProduct

The “spoke wheel” sign in hepatic focal nodular hyperplasia

2018

CLASSICS IN ABDOMINAL RADIOLOGY

medicine.medical_specialtyPathologyRadiological and Ultrasound Technologybusiness.industryUrologyGastroenterologyFocal nodular hyperplasiaContrast MediaHepatologymedicine.disease030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineFocal nodular hyperplasiamedicineHumansRadiology Nuclear Medicine and imagingbusinessAbdominal Radiology
researchProduct

Minimal Lesions of the Small Intestinal Mucosa: More than Morphology

2020

Minimal lesions of the small bowel are mucosal changes characterized by an increased number of intraepithelial lymphocytes (with or without crypt hyperplasia) and normal villous architecture. Such changes are associated with a wide spectrum of conditions, ranging from food intolerances to infections, and from drugs to immune diseases, with different clinical profiles and manifestations, which complicates the formulation of a differential diagnosis. Patient history, symptom evaluation, and histopathology are the diagnostic features needed to establish a correct diagnosis. Physicians should assist pathologists in formulating a precise morphological evaluation by taking well-oriented small int…

medicine.medical_specialtyPathologySettore MED/09 - Medicina InternaPhysiologyBiopsyDiseaseWheat HypersensitivityMucosal enteropathiesNONon-celiac gluten/wheat sensitivityDiagnosis Differential03 medical and health sciencesIntra-epithelial lymphocytes0302 clinical medicineIntolerancesPredictive Value of TestsRisk FactorsInternal medicineIntestine SmallmedicineHumansCeliac diseaseMedical historyIntestinal MucosaIntraepithelial LymphocytesImmunoglobulin A-tranglutaminase 2 depositiHyperplasiaImmunoglobulin A-tranglutaminase 2 depositisbusiness.industryGastroenterologyPotential celiac diseaseMucosal enteropathieHepatologySmall intestineIntra-epithelial lymphocytemedicine.anatomical_structureCeliac disease Immunoglobulin A-tranglutaminase 2 depositis Intra-epithelial lymphocytes Mucosal enteropathies Non-celiac gluten/wheat sensitivity Potential celiac disease030220 oncology & carcinogenesisIntraepithelial lymphocyte030211 gastroenterology & hepatologyHistopathologyDifferential diagnosisbusiness
researchProduct

Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis

2008

BACKGROUND AND STUDY AIMS: Chromoendoscopy using methylene blue is employed in the gastrointestinal tract to delineate neoplastic lesions. We tested the value of chromoendoscopy during choledochoscopy for characterization of local inflammation, neoplasias, and other alterations in patients with biliary strictures. METHODS: Patients with suspected biliary lesions were scheduled for endoscopic retrograde cholangiography with subsequent cholangioscopy. After initial inspection of the bile duct, 15 ml methylene blue (0.1 %) was administered via the working channel of the cholangioscope. Newly appearing circumscribed or unstained lesions were judged according to their macroscopic type and staini…

medicine.medical_specialtyPathologybusiness.industryBile ductGastroenterologyHistologyBile Duct DiseasesConstriction Pathologicmedicine.diseaseGastroenterologyPrimary sclerosing cholangitisStainingChromoendoscopyMethylene BlueStenosisTreatment Outcomemedicine.anatomical_structureCholestasisDysplasiaInternal medicinemedicineFeasibility StudiesHumansEndoscopy Digestive SystembusinessEndoscopy
researchProduct